Work

Innovations and ongoing challenges in digital technologies for Parkinson’s disease

Year: 2025

Type: editorial

Abstract: Parkinson’s disease (PD) is a common neurodegenerative movement disorder that affects more than 10 million people worldwide 1 . PD results in a constellation of motor and non-motor symptoms 2 , 3 , 4 , 5 , 6 that significantly impact quality of life, independence, and engagement in one’s community. Due to the degenerative nature and the different phenotypes of PD, longitudinal assessment is necessary for informing important clinical decisions such as choosing and dosing of medication, candidacy for invasive treatments (e.g., pumps and deep brain stimulation), and referral to various healthcare services (e.g., psychology, geriatric, rehabilitation). There are clear opportunities for emerging technologies to improve, automate, and make more accessible many aspects of clinical care and research in PD.

Source: npj Parkinson s Disease

DOI: 10.1038/s41531-025-00920-5

Authors: Ryan T. Roemmich, Elena Moro, Peter B. Shull

Institutions: Kennedy Krieger Institute, Johns Hopkins University, Johns Hopkins Medicine, Inserm, Centre Hospitalier Universitaire de Grenoble, Grenoble Institute of Neurosciences, Université Grenoble Alpes, Shanghai Jiao Tong University

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,890

OpenAlex ID: W4408914349

Cites: 11

Cited by: 2

Related to: 10